Oral Drug Delivery Resources
-
Drug Formulation Development: Quick Reference Guide
7/11/2022
This guide shares the steps involved in formulation development, considerations during formulation, and how partnering with an experienced CDMO can lead to a successful commercial product.
-
Strategies For Accelerating The Development Of Modified Release Oral Forms
3/3/2022
Careful selection of appropriate excipients and delivery technologies is key to the design of modified release (MR) formulations fulfilling specific performance requirements.
-
The Flux Performance Of Nanoformed And Untreated PRX Solid Suspensions
7/26/2023
Explore the application of in vitro flux assays to nanoparticles, with data on how the in vitro permeability apparatus can characterize the membrane flux performance of an API formulated as a nanosuspension.
-
Customized Release Through Dispersed Dosage Formats
6/13/2024
Typically, dosage format is based on the target product profile: how the developer envisions the product best addressing a clinical indication by maintaining population-wide efficacy.
-
Spray Drying: Advantages And Disadvantages
2/28/2022
When it comes to formulation development, pharmaceutical spray drying is one of the most versatile solutions. Review a detailed look at the steps involved in spray drying and the benefits and downsides.
-
Solubility With Lipid-Based Technologies For Oral & Injectable Formulations
11/7/2022
Innovative approaches in developing formulations can help to improve a drug's safety and efficacy. Explore the decision for selecting the best-suited technology for formulating a complex molecule.
-
Microphysiological Systems: Closing The Gap Between Models And Medicine
9/2/2025
Microphysiological systems (MPS) use human cells to model tissue function, offering faster, more predictive insights for drug discovery, safety testing, and personalized medicine—bridging gaps left by animal and 2D models.
-
Oral Controlled Delivery Of Poorly Water-Soluble Drugs
1/27/2022
Various drug delivery nanotechnologies, such as nano-suspensions, lipid microemulsions, nano-emulsions, and amorphous solid dispersions, have been critical in overcoming bioavailability challenges.
-
Identifying And Mitigating Absorption Risks With PBPK Modeling
8/8/2023
Physiologically based pharmacokinetic modeling is a powerful tool for clinical trial design that can be leveraged alongside early development experiments to reduce costs and accelerate timelines.
-
Accelerate Development Of Enabled Formulations For Poorly Soluble Drugs
8/21/2023
Explore how a platform integrating drug substance, drug product, and clinical testing within a single organization accelerates development and reduces costs, helping deliver positive outcomes earlier.